Bio Saga Headlines

Bio Saga

Monday, July 7, 2008

Ranbaxy, others to scrap 60 drug combinations

The country's leading drug makers, including Ranbaxy Laboratories, Cipla, Cadila Pharmaceuticals, Nicholas Piramal and Wockhardt, will soon withdraw about 60 drug combinations from the market.
The voluntary move comes a little more than a year after the Central Drugs Standard Control Organisation (CDSCO), the central authority that approves new drugs for marketing, had asked the drug makers to withdraw the ‘combination drugs' as they are "unnecessary" and may pose health hazards. The Drugs Controller General of India (DCGI) had banned 294 combination drugs sold under nearly 1,053 brand names from the market in June 2007. Since then, the pharma industry and the the drug authority have been locked in a legal battle.

Do you want to know more?

No comments:

Life Science and Informatics

What is this?
is this a new industry?
or a old wine in a new bottle?

Well Life Sciences and Informatics can be anything form computational biology, all omes and omics, core bioinformatics to curation and literature mining, database creation, in the area of biology, chemistry , bio-chem space.

There are number of companies in India and bangalore is the forefront as a major bio-cluster with 20 to 30 companies in this sphere.

now how good are these companies doing?
how good are they in terms of the international markets and how profitable is their business?
what do they do?
their clients?

These are some interesting things that could be discussed in this blog page...

Tag It